Capital Raise, Recapitalization

DW Healthcare and White Oak recapitalized Frontier’s client providing Growth Capital


Parnell Pharmaceuticals Holdings Ltd., an Australian-based developer with other operations in the U.S., Canada, Middle East and Asia-Pacific, develops, manufactures and markets innovative animal and human health pharmaceutical solutions for customers in the U.S. and internationally. With the animal health spend steadily growing across the world driven by the need for effective controls to limit the spread of disease among animals, Parnell Pharmaceuticals’ solutions improved (among other things) productivity yields via ethical and healthy means. Based on the demand for its proprietary and other products and based on the pet and livestock owners’ inelastic spend on animal healthcare, the Company positioned itself for compelling growth opportunities.


To capitalize on its growth opportunities, Parnell Pharmaceuticals sought to refinance its previous capital structure with new debt and equity financing in order to fund the Company’s continued growth at the lower cost of capital.


As the Company’s exclusive international adviser, Frontier conducted a far-reaching and successful competitive marketing process that produced for Parnell Pharmaceuticals strong financial partners to fund the Company’s growth plan and to provide meaningful niche market segment expertise: DW Healthcare Partners, a strong private equity partner with relevant industry expertise and experience, along with White Oak Healthcare Finance, a healthcare-focused lending firm. DW Healthcare’s equity investment and White Oak’s lending facility also enabled Parnell Pharmaceuticals to refinance its debt at significantly improved terms and to consolidate the Company’s fragmented ownership in a recapitalization transaction totaling approximately $50 million.

Related Transactions

SkyMark Refuelers, Flowmark, and Railtrucks recapitalized with Sky Island Capital

C2FO raised Growth Capital of $200 Million from preeminent investors: Softbank, Temasek, and USV

Raised Growth Capital of $20 Million with Availability to Additional Capital

Integrated Health Systems sold a majority ownership interest in a recapitalization to Traverse Pointe Partners

Temp-Con Incorporated Recapitalized with Centerfield Capital Partners and Caymus Equity

Partners in Behavioral Milestones was acquired by BioNOVUS Innovations, an affiliate of DeBruce Companies

EiKO partnered with Stephens Capital Partners LLC & Charter Oak Equity

MidState Reclamation & Trucking partnered with Stone Arch Capital through a recapitalization

360 Energy Engineers was acquired by Willdan Group, Inc.(NASDAQ:WLDN)

Western Container Company successfully consummated a refinancing of its existing debt to fund growth initiatives

MAG Trucks has secured growth financing

Avascend was acquired by Towne Park, a portfolio company of Camden Partners and HarbourVest

InkCycle has successfully completed a refinancing of its senior debt and obtained a bridge loan to fund growth

Apex Engineering International LLC completed a recapitalization of its senior debt and equity through financing provided by C3 Capital and Wells Fargo

DataCore Marketing was acquired by Subsidiaries of WPP Group, the world’s largest advertising and marketing group (NYSE: WPP)

Beacon Industries sold to OmnicomGroup (NYSE: OMC)

Southern Theatres, LLC procured a $28 million equity investment from Veronis Suhler Stevenson

Data Technology Company consummated a minority recapitalization with a prominent private equity firm

Ventria Bioscience raised Growth Capital from a private family office